CB Insights – Book of Strategy Maps: Pharma & Health Systems, 2026
Summary
The main theme of the document is the analysis of mergers and acquisitions (M&A), investments, and partnerships in the pharmaceutical industry and health systems.
Key findings include competition among leading pharmaceutical companies for market share in psychiatry, with major deals such as J&J's acquisition of Intra-Cellular for $14.6 billion. Pharmaceutical companies are using obesity as a starting point for larger metabolic portfolios, with significant deals in the MASH area. The importance of artificial intelligence in clinical trials is highlighted, where technologies help accelerate processes and improve outcomes.
Region:
Published:
Author(s):
Language:
Tech drivers:
Social drivers:
Found an inaccuracy in the description? Let us know 🙌
